Mar 11, 2024   SOURCE: PR NewsWire

Pharmaceutical Membrane Filtration Market Worth $19.6 billion | MarketsandMarkets(TM)

CHICAGO, March 11, 2024 /PRNewswire/ -- Pharmaceutical Membrane Filtration Market in terms of revenue was estimated to be worth $10.6 billion in 2024 and is poised to reach $19.6 billion by 2029, growing at a CAGR of 13.1% from 2024 to 2029 according to a new report by MarketsandMarkets(TM). Some factors contributing to the growth of the global market includes increasing adoption of single use membrane filters coupled by high purity requirements among end users, increasing R&D spending by government and private organizations, and increasing regulations for membrane filter's safety by regulatory bodies. Despite this, issues such as membrane fouling, and large capital investment are expected to hinder market growth.

https://mma.prnewswire.com/media/2297424/MarketsandMarkets_Logo.jpg

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=255408031

Browse in-depth TOC on "Pharmaceutical Membrane Filtration Market"

652 - Tables
55 - Figures
502 - Pages

Pharmaceutical Membrane Filtration Market Scope:


                 Report Coverage 
     
              Details



     Market Revenue in 2024                                             
            $10.6 billion



     Estimated Value by 2029                                            
            $19.6 billion



     Growth Rate                                             Poised to grow at a CAGR of 13.1%


      Market Size Available for  
     2022-2029



     Forecast Period            
     2024-2029



     Forecast Units             
     Value (USD Billion)



     Report Coverage              Revenue Forecast, Competitive Landscape, Growth Factors, and
                                    Trends



     Segments Covered             Product, Technique, Type, Application, And Scale Of
                                    Operation



     Geographies Covered          North America, Europe, Asia Pacific, Latin America, Middle
                                    East and Africa



     Report Highlights            Updated financial information /product portfolio of players


      Key Market Opportunities   
     Growth opportunities in emerging economies



     Key Market Drivers         
     Increasing adoption of single-use technologies

The polyethersulfone (PES) membrane filters segment accounted for the largest share of the membrane filters segment in the pharmaceutical membrane filtration market in 2023.

Based on products, the pharmaceutical membrane filtration market is segmented into membrane filters, systems, and other products. Membrane filters segment dominated the market in 2023 and is expected to dominate the market in the forecast period. Membrane filters are further segmented based on material into polyethersulfone (PES) membrane filters, polyvinylidene difluoride (PVDF) membrane filters, nylon membrane filters, polytetrafluoroethylene (PTFE) membrane filters, mixed cellulose ester & cellulose acetate (MCE & CA) membrane filters, polycarbonate track-etched (PCTE) membrane filters, and other membrane filters (PP, PC, CN, gelatin, PETE, and RC). Among these, PES membrane filters are most widely used due to their hydrophilic nature and high flow rates.

The microfiltration segment is estimated to register the highest growth rate during the forecast period in the pharmaceutical membrane filtration market.

Based on technique, the pharmaceutical membrane filtration market is segmented into microfiltration, ultrafiltration, nanofiltration, and other techniques. The other techniques segment includes reverse osmosis and ion exchange. The microfiltration segment is estimated to register the highest growth rate during the forecast period. In the pharmaceutical industry, microfiltration finds applications in clarification, purification of cell broths, the separation of cell debris, and the separation of macromolecules. The technique is used in harvesting cells in upstream bioprocessing.

The Asia Pacific region is the fastest-growing region of the pharmaceutical membrane filtration market in 2023.

Based on the region, the pharmaceutical membrane filtration market is segmented into major regions: North America, Europe, Asia Pacific, Latin America, Middle East and Africa. The Asia Pacific is anticipated to register fastest growth in the pharmaceutical membrane filtration owing to the increasing technological advancement in nanofiber technologies, manufacturing facility expansions by pharmaceutical companies, high government investments & fundings for R&D, and growing biotechnology industries.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=255408031

Pharmaceutical Membrane Filtration Market Dynamics:

Drivers:

1. Increasing adoption of single-use technologies

Restraints:

1. Membrane fouling issues

Opportunities:

1. Growth opportunities in emerging economies

Challenge:

1. Increased cost and reduced speed & yield of filters

Key Market Players of Pharmaceutical Membrane Filtration Industry:

Key players in the pharmaceutical membrane filtration market include Merck KGaA (Germany), Danaher Corporation (US), Sartorius AG (Germany), Thermo Fisher Scientific, Inc. (US), 3M Company (US), Parker Hannifin Corporation (US), Repligen Corporation (US), Asahi Kasei Corporation (Japan), Eaton Corporation plc (Ireland), GEA Group (Germany), Corning Incorporated (US), Alfa Laval Corporate AB (Sweden), Donaldson Company, Inc. (US), Saint-Gobain (France), MANN+HUMMEL International GmbH & Co. KG (Germany), Meissner Filtration Products, Inc. (US), Cole-Parmer Instrument Company, LLC (US), Applexion (France), Cantel Medical Corp. (US), W. L. Gore & Associates Inc. (US), Membrane Solutions (US), Amazon Filters Ltd. (UK), Toyo Roshi Kaisha, Ltd. (Japan), Porvair plc (UK), Sterlitech Corporation (US), Synder Filtration, Inc. (US), Graver Technologies, LLC (US), Koch Membrane Systems, Inc. (US), Nupore Filtration Systems (India), and Cobetter Filtration Equipment Co., Ltd. (China).

The primary interviews conducted for this report can be categorized as follows:

    --  By Respondent: Supply Side- 70% and Demand Side 30%
    --  By Designation: Managers - 45%, CXO & Directors - 30%, and Executives -
        25%
    --  By Region: North America -40%, Europe -25%, Asia-Pacific -20%, Latin
        America -10% and Middle East & Africa- 5%

Recent Developments of Pharmaceutical Membrane Filtration Industry:

    --  In November 2023, Repligen Corporation (US) launched a holder-free,
        self-contained tangential flow filtration (TFF) device for the
        advancement of downstream flat sheet TFF technology for ultrafiltration
        and diafiltration (UF/DF).
    --  In October 2023, Cytiva (US) announced the opening of a 33,000 ft2
        manufacturing facility in Pune, India. The new facility will manufacture
        bioprocessing equipment such as tangential flow, virus filtration, and
        inactivation systems.

Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=255408031

Pharmaceutical Membrane Filtration Market - Key Benefits of Buying the Report:

The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall pharmaceutical membrane filtration market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.

The report provides insights on the following pointers:

    --  Analysis of key drivers (increasing adoption of single-use technologies,
        stringent regulatory requirements, rising R&D spending in pharmaceutical
        and biotechnology industries, and increasing purity requirements in
        end-use industries), restraints (membrane fouling issues and high
        capital investment requirements to limit entry of smaller players),
        opportunities (growing opportunities in emerging economies, advances in
        nanofiltration technology), and Challenges (increased cost and reduced
        speed & yield of filters) influencing the growth of the market.
    --  Product Development/Innovation: Detailed insights on newly launched
        products of the pharmaceutical membrane filtration market
    --  Market Development: Comprehensive information about lucrative markets -
        the report analyses the market across varied regions.
    --  Market Diversification: Exhaustive information about new products,
        untapped geographies, recent developments, and investments in the
        pharmaceutical membrane filtration market
    --  Competitive Assessment: Merck KGaA (Germany), Danaher Corporation (US),
        Sartorius AG (Germany), Thermo Fisher Scientific, Inc. (US), 3M Company
        (US), Parker Hannifin Corporation (US), Repligen Corporation (US), Asahi
        Kasei Corporation (Japan), Eaton Corporation plc (Ireland), GEA Group
        (Germany), Corning Incorporated (US), Alfa Laval Corporate AB (Sweden),
        Donaldson Company, Inc. (US), among others in the market.

Related Reports:

Pharmaceutical Filtration Market - Global Forecasts to 2028

Tangential Flow Filtration Market - Global Forecasts to 2028

Sterile Filtration Market - Global Forecasts to 2028

Sterility Testing Market - Global Forecasts to 2028

Laboratory Filtration Market - Global Forecasts to 2026

About MarketsandMarkets(TM):

MarketsandMarkets(TM) has been recognized as one of America's best management consulting firms by Forbes, as per their recent report.

MarketsandMarkets(TM) is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.

Earlier this year, we made a formal transformation into one of America's best management consulting firms as per a survey conducted by Forbes.

The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we work with several Forbes Global 2000 B2B companies - helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore(TM) (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.

To find out more, visit www.MarketsandMarkets(TM).com or follow us on Twitter, LinkedIn and Facebook.

Contact:
Mr. Aashish Mehra
MarketsandMarkets(TM) INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Research Insights: https://www.marketsandmarkets.com/ResearchInsight/pharmaceutical-membrane-filtration-market.asp
Visit Our Website: https://www.marketsandmarkets.com/
Content Source: https://www.marketsandmarkets.com/PressReleases/pharmaceutical-membrane-filtration.asp

Logo: https://mma.prnewswire.com/media/2297424/MarketsandMarkets_Logo.jpg

View original content:https://www.prnewswire.com/news-releases/pharmaceutical-membrane-filtration-market-worth-19-6-billion--marketsandmarkets-302085009.html

SOURCE MarketsandMarkets